News Briefs: Injunction Lifted On Medtronic’s CoreValve; Tentative J&J Hip Settlement
This article was originally published in The Gray Sheet
Executive Summary
A German court gives Medtronic the right to sell its CoreValve in Germany again. Johnson & Johnson has agreed to a tentative settlement of $4 billion to patients who received its ASR metal-on-metal hip. More news briefs.
You may also be interested in...
Abbott Enters Electrophysiology Fray With Topera, ACT Deals
The diversified company is entering the atrial fibrillation catheter ablation for the first time. It is acquiring Afib ablation mapping system maker Topera and has gained rights to buy catheter developer Advanced Cardiac Therapeutics.
Edwards Wins Latest Round In TAVI Patent Dispute With Medtronic
A jury in Delaware awarded Edwards $393.6 million in damages plus royalties after determining Medtronic’s CoreValve infringes Edwards’ Cribier patent. While Medtronic might be paying royalties to Edwards for the next several years, Medtronic also got some very positive news last week: FDA approved CoreValve for patients too sick for surgery months earlier than expected.
News Briefs: DePuy ASR Settlement; Tandem Diabetes IPO; AtriCure Trial
DePuy settles bulk of U.S. ASR suits. Tandem Diabetes closes $138 million IPO. AtriCure gets go-ahead for new AtriClip stroke. More news.